HIV/AIDS patients’ perspectives on adhering to regimens containing protease inhibitors
Journal of General Internal MedicinePublished 1 September 1998Open access
Valerie E. Stone, Jennifer Clarke, Joan Lovell, Kathleen A. Steger, Lisa R. Hirschhorn, Stephen Boswell
Citations117
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Among those with HIV/AIDS, awareness of PIs and their effectiveness is substantial, owing to the impact of informal networks and medical providers, and this early positive “reputation” of PI may enhance motivation for adherence.
Abstract
Among those with HIV/AIDS, awareness of PIs and their effectiveness is substantial, owing to the impact of informal networks and medical providers. This early positive "reputation" of PIs may enhance motivation for adherence. Those who are taking PIs invest substantial effort adhering to these complex regimens, but resent the need to make medications the focus of their lives.
Keywords
Medicine
New England Journal of MedicineDeclining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
9,465 Citations1998Frank J. Palella, Kathleen M. Delaney +6 more
The recent declines in morbidity and mortality due to AIDS are attributable to the use of more intensive antiretroviral therapies.
Focus Groups as Qualitative Research
8,719 Citations1997David Morgan
Annals of Internal MedicineGuidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
5,233 Citations1998
BMJQualitative Research: Rigour and qualitative research
2,673 Citations1995Nicholas Mays, Catherine Pope
New England Journal of MedicineA Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
2,666 Citations1997Scott M. Hammer, Kathleen Squires +14 more
Treatment with indinavir, zidovudine, and lamivudine as compared with zidvudine and lam ivudine alone significantly slows the progression of HIV-1 disease in patients with 200 CD4 cells or fewer per cubic millimeter and prior exposure to zidavudine.
New England Journal of MedicineTreatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1,900 Citations1997Roy M. Gulick, John W. Mellors +14 more
In most HIV-infected patients with prior antiretroviral therapy, the combination of indinavir, zidovudine, and lamivudine reduces levels of HIV RNA to less than 500 copies per milliliter for as long as one year.
JAMAAntiretroviral Therapy for HIV Infection in 1998
1,016 Citations1998Charles C. J. Carpenter, Margaret A. Fischl +12 more
Accumulating data from clinical and pathogenesis studies continue to support early institution of potent antiretroviral therapy in patients with HIV infection, and increased complexity in HIV management requires ongoing monitoring of new data for optimal treatment of HIV infection.
NatureIn vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
979 Citations1995Jon H. Condra, William A. Schleif +14 more
Five resistant variants isolated from patients undergoing therapy with the protease inhibitor MK-639 exhibited cross-resistance to all members of a panel of six structurally diverse protease inhibitors, suggesting that com-bination therapy with multiple protease inhibition may not prevent loss of antiviral activity resulting from resistance selection.
New England Journal of MedicineHIV-Protease Inhibitors
861 Citations1998Charles Flexner
Inhibitors of human immunodeficiency virus (HIV)–encoded protease, combined with nucleoside analogues with antiretroviral activity, cause profound and sustained suppression of viral replication, reduce morbidity, and prolong life in patients with HIV infection.
JAMAAntiretroviral Therapy for HIV Infection in 1997
728 Citations1997Charles C. J. Carpenter
New data have provided a stronger rationale for earlier initiation of more aggressive therapy than previously recommended and reinforce the importance of careful selection of initial drug regimen for each patient for optimal long-term clinical benefit and adherence.
AIDS CareDeterminants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance
506 Citations1996N. Singh, Cheryl Squier +4 more
The prevalence and variables associated with compliance with antiretroviral therapy in patients with human immunodeficiency virus infection, by means of a longitudinal observational study of 46 patients aged 23 to 68 years, are assessed.
JAMAAntiretroviral Therapy for HIV Infection in 1996
309 Citations1996Charles C. J. Carpenter
Recent data on HIV pathogenesis, methods to determine plasma HIV RNA, clinical trial data, and availability of new drugs point to the need for new approaches to treatment, and therapeutic approaches need to be updated as new data continue to emerge.
The American Journal of MedicineCompliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic
225 Citations1992Jeffrey H. Samet, Howard Libman +8 more
High compliance with zidovudine was achieved by HIV-infected patients in a municipal hospital clinic, many of whom had a history of intravenous drug use and may be enhanced by a patient's belief that it prolongs life and the use of a medication timer for proper dosing.
New England Journal of MedicineImpact of Combination Therapy for HIV Infection on Inpatient Census
217 Citations1997Ramón A. Torres, Michael R. Barr
To the Editor: St. Vincent's Hospital and Medical Center in New York is located in the Greenwich Village–Chelsea section of lower Manhattan, one of the areas with the highest density of human immunodeficiency virus (HIV) infection in the United States.
Journal of Acquired Immune Deficiency Syndromes & Human RetrovirologyAcceptance and Adherence With Antiretroviral Therapy Among HIV-Infected Women in a Correctional Facility
193 Citations1998Farzad Mostashari, Elise D. Riley +2 more
Acceptance and adherence with antiretroviral agents appear to be significantly associated with trust in medications, trust in the health care system, and interpersonal relationships with physicians and peers.
JAMAPatient Compliance and Drug Failure in Protease Inhibitor Monotherapy
193 Citations1996Geertrui F. Vanhove
The Journal of Infectious DiseasesIn Vivo Resistance to a Human Immunodeficiency Virus Type 1 Proteinase Inhibitor: Mutations, Kinetics, and Frequencies
172 Citations1996Helmut Jacobsen, Markus Hänggi +6 more
There was a good relationship between genotypic analysis of saquinavir resistance and data from virus assays, confirming that Leu90-->Met and Gly48-->Val are the essential exchanges in the proteinase that determine loss of sensitivity to this inhibitor.
PubMedAntiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.
151 Citations1996Charles C. J. Carpenter, Margaret A. Fischl +12 more
JAMAProtease Inhibitors in the Homeless
143 Citations1997David R. Bangsberg
The standard of care for HIV-infected patients has quickly become combination antiretroviral therapy with a protease inhibitor, and the term "Lazarus effect" has been used to describe the return to functional status of some patients with end-stage acquired immunodeficiency syndrome (AIDS).
Archives of Internal MedicineA Cohort Study of Drug Users' Compliance With Zidovudine Treatment
142 Citations1994Barbara Broers
Injecting drug users tend to delay the start of zidovudine treatment, but once they have started, their compliance is no worse than the compliance of patients from other risk groups, which has important implications for clinical trials, medical care, and public health.
AIDS CareZidovudine adherence among individuals with HIV infection
119 Citations1995Richard D. Muma, Michael W. Ross +2 more
Investigating the relationships among health beliefs, attitudes, and zidovudine compliance in individuals with HIV infection suggests that non-compliance is related to attitudes and beliefs about zidvudine, consistent with the HBM, which holds that the balance between barriers and benefits of a health-related behaviour are significant determinants of outcome.
Health Education MonographsThe Potential of Grounded Theory for Health Education Research: Linking Theory and Practice
81 Citations1978Patricia Dolan Mullen, Richard J. Reynolds
The grounded theory method—an inductive approach usually used with participant observation and interview data—is described, and the major arguments for its value are presented, suggesting the empirical generation of middle-range theory can provide a strong link between more general theory and situations faced by practitioners.
Annals of Internal MedicineProtease Inhibitors for HIV Infection
62 Citations1996John G. Bartlett
Squinavir is the first protease inhibitor to acquire FDA approval and is a potent inhibitor of HIV replication in vitro, but in vivo activity is modest at the recommended doses because of poor absorption and rapid hepatic metabolism.
Journal of General Internal MedicineZidovudine Adherence in Persons with AIDS The Relation of Patient Beliefs About Medication to Self-Termination of Therapy
47 Citations1997Meredith Y. Smith, PhD +3 more
Patients' beliefs about ZDV were significantly associated with adherence-related behavior, and those who had self-terminatedZDV treatment believed that taking the drug was harmful, were skeptical of its ability to prevent illness, and felt that physicians' directives about medication usage in general could be disregarded.
Archives of DermatologyUpdate: Trends in AIDS Incidence— United States, 1996
38 Citations1998
The findings indicate that HIV therapies are having a widespread beneficial impact on the rate of HIV disease progression in the United States.
New England Journal of MedicineBattling HIV on Many Fronts
34 Citations1997Robert Steinbrook
Two reports in this issue of the Journal provide compelling data on the benefits of a three-drug regimen consisting of a protease inhibitor and two nucleoside analogues.
PubMedZidovudine therapy in an inner city population.
30 Citations1990Jonathan E. Samuels, Josephine Hendrix +4 more
It is concluded that zidovudine can be administered to intravenous drug users and others in an inner city clinic with acceptable compliance and tolerance.
JAMAAIDS in 1996 Much Accomplished, Much to Do
14 Citations1996Anthony S. Fauci
A number of recent research advances have led to a greater understanding of the pathogenic mechanisms of human immunodeficiency virus (HIV) disease and form the basis for therapeutic and vaccine strategies and have practical, and even immediate, implications for the care of HIV-infected individuals.